News

A recent modelling study by ESiOR Oy and VTT Technical Research Centre of Finland assessed the cost-effectiveness of a machine learning-based risk prediction tool for

The Societal Value of Clinical Drug Trials in Finland: 10 Million Euros per Trial A study by ESiOR Oy and Pharma Industry Finland conducted in

Pulmonary Hypertension in Finland: Key Findings from the FINPAH Study (2008–2020) The FINPAH study offers valuable insights into pulmonary arterial hypertension (PAH) and chronic thromboembolic

A recent meta-analysis published in Ophthalmology and Therapy sheds light on the visual disturbances reported by patients following bilateral implantation of the PanOptix trifocal intraocular

What an Incredible Journey This Year Has Been! As 2024 draws to a close, the elves at ESiOR are taking a moment to reflect on

It’s a pleasure to share some exciting news just before the holidays: Noora Jämsén has joined our team!  Noora is a designer specialized in service design,

We’re thrilled to be part of these two events this November, bringing insights and innovation to healthcare and health economics. Pharmacy Days 2024 This weekend,

At Pharmacy days 2024, we will present no less than four innovative posters, the results of each of which will help to increase the effectiveness

We are participating in the HealthTech Investor Summit on 9-11 December 2024 at the Bruges Congress and Convention Center (BMCC), Belgium. The HealthTech Investor Summit

We are excited to announce that Erkki Soini will be speaking at the Digital Health Society Summit on November 6th, under the theme “Who Are

On September 30, 2024, over 400 professionals gathered for a symposium organized by the Finnish Biobank Cooperative- FINBB and Fingenious. The symposium convened medical, biotechnology,